The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
SHANGHAI,Feb. 13,2025-- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI),an innovative provider of digital-content products and services in China,today announced an in-depth
TVU Networks provided professional broadcasting solutions to cover one of the world\'s largest religious gatherings.
GUANGZHOU,China,Feb. 11,2025--Vipshop Holdings Limited (NYSE: VIPS),a leading online discount retailer for brands in China ("Vipshop" or the "Company"),today announced that it plan
BEIJING,Feb. 11,2025--In a world where AI,digitalization,and geopolitical shifts are reshaping business strategy,companies must position themselves to scale effectively and adapt to changes.Cheung Kon
ASEAN-UK SAGE is the UK\'s flagship education programme in Southeast Asia,supporting girls and marginalised communities to access education and improve foundational learning.
- Earnings Call to Begin at 8:00 A.M. EST – SINGAPORE,Feb. 11,2025-- ChinaYuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"),announced today that it will b
Agency action and stable outlook underscore territory\'s stability,position as global financial services hub
New whitepaper presents independent research on print performance,sustainability,and security,helping businesses optimise their workplace technology
LISHUI,China,Feb. 11,2025-- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"),announced today that the Company\'s Board of Directors approved on January 21,2025 to e
03-13
03-13
03-12
03-12
03-12
03-12
03-12
03-12
03-12
03-12
